Archive - September 2024
World Sepsis Day 2024 highlights need for better sepsis treatments
How the immune system fails as cancer arises
Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis
FDA Approves Ebglyss (lebrikizumab-lbkz) for the Treatment of Atopic Dermatitis
Lilly $1.8 billion investment to bolster Irish manufacturing
Enzyme replacement therapy: improving outcomes in rare disease
Laughter may be as effective as drops for dry eyes
FDA Approves Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy